News

Researchers have recently discovered that the enzyme, telomerase, plays a role in abnormal blood vessel formation in lab mice and this discovery may lead to new therapies in treating the wet form ...

EyePoint Pharmaceuticals announced the completion of the Phase 2 trial of their new experimental drug, vorolanib, for the treatment of wet age-related macular degeneration.

The current available therapies available to treat wet AMD involve intravitreal injections delivered every month to the back of the eye. 

A recent study reveals that one anti-VEGF treatment is more effective than another commonly used treatment.

Researchers believe the flavonoids in oranges offer protection against late stage macular degeneration.

Study results offer hope to patients with wet macular degeneration who are receiving anti-VEGF injections.

I don't want to see ANY progression on their photographs or optical scans. If I do, I modify strategies.

The FDA just approved ranibizumab (Lucentis) as an ocular implant to be injected into the eye for people with wet macular degeneration, based upon the successful Archway study run under the FDA umb...

A recent study was published in the journal Science Advances which sheds light on how a build-up of damaging DNA in the eyes of people with macular degeneration can lead to blindness.